A Risk-Benefit Assessment of Levofloxacin in Respiratory,...

Drug Safety 2001 / 03 Vol. 24; Iss. 3

A Risk-Benefit Assessment of Levofloxacin in Respiratory, Skin and Skin Structure, and Urinary Tract Infections

Dr Steven J. Martin, Rose Jung, Cory G. Garvin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
DOI:
10.2165/00002018-200124030-00004
Date:
March, 2001
File:
PDF, 223 KB
english, 2001
Conversion to is in progress
Conversion to is failed